炎症性肠病
医学
生物标志物
抗体
免疫学
整合素
疾病
溃疡性结肠炎
单克隆抗体
炎症性肠病
结肠炎
免疫病理学
危险分层
炎症
癌症研究
克罗恩病
作者
Yoichi Kakuta,Dalin Li,Philip Debbas,Soshi Okazaki,Motoi Sawahashi,Shaohong Yang,Hideya Iwaki,Daisuke Okamoto,Hiroshi Nagai,Yusuke Shimoyama,Takeo Naito,Rintaro Moroi,Masatake Kuroha,Hisashi Shiga,Yoshitaka Kinouchi,Tsuyoshi Shirai,Hiroshi Fujii,Dermot P.B. McGovern,Atsushi Masamune
摘要
BACKGROUND: Inflammatory bowel diseases (IBDs), including ulcerative colitis (UC) and Crohn's disease (CD), have complex pathologies requiring precise diagnostic tools. We evaluated the clinical utility of anti-integrin αvβ6 antibodies in diagnosing UC, focusing on differences between a U.S. cohort (self-reported White) and a Japanese cohort, and additionally assessed whether combining anti-αvβ6 with anti-EPCR improved diagnostic performance. METHODS: Serum anti-αvβ6 antibody levels were measured in 1138 participants (514 in the U.S. cohort, 624 in the Japanese cohort), including 1093 IBD cases and 45 healthy control subjects. Positivity rates and titers were compared between cohorts, and associations with clinical subphenotypes and anti-EPCR were examined. RESULTS: Anti-αvβ6 positivity was significantly higher in UC patients (85.4%) than in CD patients (16.4%) or control subjects (0%). Within UC, high positivity was observed across all disease extents, with only minor cohort differences. Longer disease duration was associated with lower positivity in both cohorts. In CD, the U.S. cohort showed higher positivity (23.4%) than the Japanese cohort (10.1%), particularly in colonic CD. Absence of ileal involvement, strictures, or perianal disease was associated with higher positivity. Anti-αvβ6 and anti-EPCR levels were strongly correlated, but their expression patterns differed in primary sclerosing cholangitis-associated IBD. Combining anti-αvβ6 and anti-EPCR improved UC diagnostic accuracy (area under the curve, 0.98; 95% confidence interval, 0.95-1.00) over either antibody alone (P = .00264). CONCLUSIONS: Anti-αvβ6 is a valuable biomarker for UC diagnosis. However, this study demonstrated differences in its behavior between U.S. and Japanese cohorts, particularly in CD. Cohort-informed interpretation and combined antibody testing may improve diagnostic precision and disease stratification in IBD.
科研通智能强力驱动
Strongly Powered by AbleSci AI